Relastin
Search documents
Bausch Health (BHC) Q4 2025 Earnings Transcript
Yahoo Finance· 2026-02-18 23:51
Core Insights - Bausch Health Companies Inc. achieved its eleventh consecutive quarter of growth in both revenue and adjusted EBITDA, exceeding guidance on all key metrics for the year [1][6][12] - The company reported a 9% increase in revenue for Q4 2025, with adjusted EBITDA also rising by 9% compared to the previous year [6][14] - The acquisition of Shibo, a full-service aesthetics distribution platform in China, is expected to enhance the company's commercial presence in a key market [7][29] Financial Performance - For Q4 2025, revenue was $1,391,000,000, reflecting a 9% increase year-over-year, while adjusted EBITDA was $773,000,000, also up 9% [14][19] - Full-year revenue growth was 7% on a reported basis and 6% on an organic basis, with adjusted EBITDA growth of 10% [9][10][19] - The company generated over $1,000,000,000 in adjusted operating cash flow for the year and reduced net debt by several hundred million dollars [7][19] Segment Performance - Salix segment revenues increased by 9% year-over-year in Q4, driven by strong demand and effective promotional strategies [14][15] - The International segment saw revenues of $306,000,000, a 10% increase on a reported basis, with notable growth in EMEA and LATAM regions [15][32] - Solta Medical segment revenues were $137,000,000, slightly down by 1% due to a transition in distribution, but expected to grow in the future [16][27] Strategic Initiatives - The company plans to continue prioritizing high-value initiatives and business development opportunities to enhance long-term growth [5][23] - For 2026, Bausch Health expects revenues between $5,250,000,000 and $5,400,000, representing a 3% year-over-year increase at the midpoint [21][22] - The company aims to optimize its capital structure and pursue value maximization for shareholders through strategic asset monetization [23][63] Market Outlook - The company anticipates stronger growth in the second half of 2026, driven by ongoing operational improvements and strategic initiatives [22][24] - Bausch Health is focused on leveraging its commercial capabilities and expanding its portfolio through targeted acquisitions and innovation [61][62] - The company remains committed to delivering sustainable results through its five strategic pillars: people, growth, innovation, efficiency, and unlocking value [34][35]